The global cerebrospinal fluid management market was valued at $1.20 Billion in 2016 and is projected to reach $1.56 Billion by 2022, at a CAGR of 4.4%. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.

Factors such as the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population are driving the growth of the CSF management market.

Download FREE Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160672575

There is a significant shortage of neurophysicians and neurosurgeons worldwide. With the rapidly increasing aging population, the current number of neurosurgeons is inadequate to meet the healthcare demand.

One of the greatest limitations is the inability to produce a sufficient number of trained neurosurgeons in the required amount of time. This shortage of trained professionals in neurosurgery extends to North America, Europe, Asia Pacific, Latin America, and Africa.

However, developing economies such as Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world with a large patient base of hydrocephalus. The presence of such a huge patient base in this region, along with rising healthcare expenditure, is expected to serve as an opportunity for players in the CSF management market

To Know More @
https://www.marketsandmarkets.com/Market-Reports/cerebrospinal-fluid-management-market-160672575.html